• LAST PRICE
    0.0017
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0017
  • Day Range
    ---
  • 52 Week Range
    Low 0.0001
    High 0.0052
  • Volume
    ---

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
Table Data Not Available
Data delayed at least 15 minutes.
No documents available
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesFPMI
FluoroPharma Medical Inc
58.3K
0.0x
---
United StatesPFND
Pathfinder Cell Therapy Inc
66.7K
-0.1x
---
United StatesFWDG
FutureWorld Corp
36.3K
-0.1x
---
United StatesMYRX
Myrexis Inc
34.5K
0.0x
---
United StatesHDVY
Health Discovery Corp
41.2K
0.0x
---
United StatesBSSP
Baseline Productions Inc
37.2K
0.0x
---
As of 2023-02-07

Company Information

FluoroPharma Medical, Inc., formerly Commercial E-Waste Management Inc., is a biopharmaceutical company specializing in discovering, developing and commercializing molecular imaging pharmaceuticals with applications in the area of cardiology. The Company operates through biopharmaceutical research and development segment. It is focused on the development of cardiovascular imaging agents that can detect and assess acute and chronic forms of coronary artery disease (CAD). It has two clinical-stage molecular imaging pharmaceutical product candidates: Flourine-18 (18-F) TPP (BFPET), which includes a ((18F)-labeled cationic lipophilic tetraphenylphosphonium ion (18-F TPP) as an imaging agent designed for use in stress-testing for patients with presumptive or proven CAD, and 18-F FCPHA (CardioPET), which includes Trans-9-(18F)-Fluoro-3, 4-Methyleneheptadecanoic Acid (18-F FCPHA) as a molecular imaging agent designed to assess myocardial blood flow and metabolism in patients with CAD.

Contact Information

Headquarters
8 Hillside Ave Ste 207MONTCLAIR, NJ, United States 07042-2129
Phone
973-744-1565
Fax
617-482-3337

Executives

Independent interim chairman of the board
Walter Witoshkin
President, Treasurer, Company Secretary
Ambrose Egbuonu
Chief Executive Officer, Director
Thomas Tulip
Chief Financial Officer, Controller, Director
Frank Igwealor
Independent Director
William Lewis

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$58.3K
Revenue (TTM)
$0.00
Shares Outstanding
34.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-0.08
Book Value
$-0.30
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.